Global Catheter-Related Bloodstream Infection Market Report 2024

Catheter-Related Bloodstream Infection Global Market Report 2024 – By Treatment (Antibiotic Lock Therapy, Anti-Microbial Agents), By Source Of Infection Or Causative Agents (Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Catheter-Related Bloodstream Infection Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Catheter-Related Bloodstream Infection Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Catheter-Related Bloodstream Infection Market Definition

Catheter-related bloodstream infection (CRBSI) is a type of infection that occurs when bacteria or fungi enter the bloodstream through a catheter, a tube inserted into a vein to deliver medications or nutrients. It is a serious healthcare-associated infection that can lead to sepsis and other complications. Prompt diagnosis and treatment are essential to prevent severe outcomes.

The main treatments for catheter-related bloodstream infection are antibiotic lock therapy and anti-microbial agents. Antibiotic lock therapy involves instilling a concentrated antibiotic solution into a catheter lumen, which is then left in place for a prolonged period to prevent or eradicate catheter-related infections without systemic administration. It is commonly used in patients with central venous catheters to manage and prevent catheter-related bloodstream infections. These sources of infection or causative agents such as staphylococcus aureus, acinetobacter baumannii, escherichia coli (e. coli), klebsiella pneumoniae (k. pneuminiae), candida species (candida sp.), pseudomonas aeruginosa (p. aeruginsa), and others. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Catheter-Related Bloodstream Infection Market Segmentation

The catheter-related bloodstream infection market covered in this report is segmented –

1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents

2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneuminiae), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginsa), Other Source Of Infection Or Causative Agents

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Global Catheter Related Bloodstream Infection Market Size 2023 to 2028: Graph

Catheter-Related Bloodstream Infection Market Size 2024 And Growth Rate

The catheter-related bloodstream infection market size has grown strongly in recent years. It will grow from $1.44 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising incidence of chronic diseases, increased awareness and education, rise in hospital-acquired infections, the growing elderly population, and enhanced infection control programs in hospitals and healthcare settings.

Catheter-Related Bloodstream Infection Market Growth Forecast

The catheter-related bloodstream infection market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing healthcare-associated infections (hais), rising awareness and training, enhanced awareness and training programs on infection control practices, expansion of healthcare infrastructure, increase in geriatric population, supportive government policies and initiatives. Major trends in the forecast period include biomaterial innovations, smart catheter technology, the development of more effective catheter lock solutions with advanced antimicrobial properties, innovations in sterilization processes for catheters, and automated flushing systems.

Catheter-Related Bloodstream Infection Market Driver: Impact Of Hospital-Acquired Infections On The Catheter-Related Bloodstream Infection Market

The rising prevalence of hospital-acquired infections is expected to propel the growth of the catheter-related bloodstream infection market going forward. Hospital-acquired infections (HAIs) are infections that patients acquire while receiving treatment for other conditions within a healthcare setting, typically manifesting 48 hours or more after admission. An increase in hospital-acquired infections can be attributed to various factors such as antimicrobial resistance, inadequate infection control measures, and patient susceptibility. Catheter-related bloodstream infections contribute significantly to hospital-acquired infections due to their invasive nature and potential for microbial colonization, posing risks to patients with indwelling catheters. For instance, in January 2023, according to the National Library of Medicine, a US-based biomedical library, the global healthcare-associated infection (HAI) rate was 0.14%, increasing annually by 0.06%. Therefore, the rising prevalence of hospital-acquired infections will drive the growth of the catheter-related bloodstream infection market.

Global Catheter-Related Bloodstream Infection Market Major Players

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Global Catheter-Related Bloodstream Infection Market Trend: Innovative Catheter Lock Solutions Enhanced Catheter-Related Bloodstream Infection Market

Major companies operating in the catheter-related bloodstream infection market are developing innovative catheter lock solutions to enhance infection prevention and improve patient outcomes. A catheter lock solution is a liquid instilled into a catheter to prevent infections and maintain catheter patency between uses. For instance, in November 2023, CorMedix Inc., a US-based biopharmaceutical company focused on developing and commercializing therapeutic products, received US Food and Drug Administration approval for DefenCath (taurolidine and heparin) catheter lock solution for adult patients with kidney failure undergoing chronic hemodialysis via central venous catheter (CVC). This antimicrobial and antifungal solution is tailored to reduce catheter-related bloodstream infections (CRBSIs), combining heparin for anticoagulation with taurolidine's broad-spectrum antimicrobial properties.

Catheter-Related Bloodstream Infection Market Merger And Acquisition: CEMMA Medical And Lipocoat BV Partner To Advance CVC Catheter Solutions

In April 2022, CEMMA Medical Company Limited, a Taiwan-based provider of high-end medical supplies and services, partnered with LipoCoat BV to develop a coated central venous catheter (CVC) for sustainable infection control. The partnership combines CEMMA's catheter expertise and LipoCoat's bio-inspired coating technology, which aims to provide an industry-leading CVC catheter solution to address the global challenge of healthcare-associated infections. LipoCoat BV is a Netherlands-based biotechnology company that specializes in bio-inspired coating technology.

Regional Insights For The Global Catheter-Related Bloodstream Infection Market

North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the catheter-related bloodstream infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The catheter-related bloodstream infection market consists of revenues earned by entities by providing services such as blood culture testing, catheter flushing and maintenance, aseptic catheter insertion, hand hygiene training, and compliance monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The catheter-related bloodstream infection market also includes sales of catheters, catheter insertion kits, catheter maintenance equipment, monitoring and diagnostic devices, and infection control equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The catheter-related bloodstream infection research report is one of a series of new reports from The Business Research Company that provides catheter-related bloodstream infection market statistics, including the catheter-related bloodstream infection industry's global market size, regional shares, competitors with a catheter-related bloodstream infection market share, detailed catheter-related bloodstream infection market segments, market trends and opportunities, and any further data you may need to thrive in the catheter-related bloodstream infection industry. This catheter-related bloodstream infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Catheter-Related Bloodstream Infection Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $1.53 billion
Revenue Forecast In 2033 $1.93 billion
Growth Rate CAGR of 6.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneuminiae), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginsa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Catheter-Related Bloodstream Infection Market Characteristics

    3. Catheter-Related Bloodstream Infection Market Trends And Strategies

    4. Catheter-Related Bloodstream Infection Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Catheter-Related Bloodstream Infection Market Size and Growth

    5.1. Global Catheter-Related Bloodstream Infection Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Catheter-Related Bloodstream Infection Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Catheter-Related Bloodstream Infection Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Catheter-Related Bloodstream Infection Market Segmentation

    6.1. Global Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Antibiotic Lock Therapy

    Anti-Microbial Agents

    6.2. Global Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Staphylococcus Aureus

    Acinetobacter Baumannii

    Escherichia Coli (E. Coli)

    Klebsiella Pneumoniae (K. Pneumonia)

    Candida Species (Candida Sp.)

    Pseudomonas Aeruginosa (P. Aeruginosa)

    Other Source Of Infection Or Causative Agents

    6.3. Global Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Catheter-Related Bloodstream Infection Market Regional And Country Analysis

    7.1. Global Catheter-Related Bloodstream Infection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Catheter-Related Bloodstream Infection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Catheter-Related Bloodstream Infection Market

    8.1. Asia-Pacific Catheter-Related Bloodstream Infection Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Catheter-Related Bloodstream Infection Market

    9.1. China Catheter-Related Bloodstream Infection Market Overview

    9.2. China Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Catheter-Related Bloodstream Infection Market

    10.1. India Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Catheter-Related Bloodstream Infection Market

    11.1. Japan Catheter-Related Bloodstream Infection Market Overview

    11.2. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Catheter-Related Bloodstream Infection Market

    12.1. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Catheter-Related Bloodstream Infection Market

    13.1. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Catheter-Related Bloodstream Infection Market

    14.1. South Korea Catheter-Related Bloodstream Infection Market Overview

    14.2. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Catheter-Related Bloodstream Infection Market

    15.1. Western Europe Catheter-Related Bloodstream Infection Market Overview

    15.2. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Catheter-Related Bloodstream Infection Market

    16.1. UK Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Catheter-Related Bloodstream Infection Market

    17.1. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Catheter-Related Bloodstream Infection Market

    18.1. France Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Catheter-Related Bloodstream Infection Market

    19.1. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Catheter-Related Bloodstream Infection Market

    20.1. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Catheter-Related Bloodstream Infection Market

    21.1. Eastern Europe Catheter-Related Bloodstream Infection Market Overview

    21.2. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Catheter-Related Bloodstream Infection Market

    22.1. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Catheter-Related Bloodstream Infection Market

    23.1. North America Catheter-Related Bloodstream Infection Market Overview

    23.2. North America Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Catheter-Related Bloodstream Infection Market

    24.1. USA Catheter-Related Bloodstream Infection Market Overview

    24.2. USA Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Catheter-Related Bloodstream Infection Market

    25.1. Canada Catheter-Related Bloodstream Infection Market Overview

    25.2. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Catheter-Related Bloodstream Infection Market

    26.1. South America Catheter-Related Bloodstream Infection Market Overview

    26.2. South America Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Catheter-Related Bloodstream Infection Market

    27.1. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Catheter-Related Bloodstream Infection Market

    28.1. Middle East Catheter-Related Bloodstream Infection Market Overview

    28.2. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Catheter-Related Bloodstream Infection Market

    29.1. Africa Catheter-Related Bloodstream Infection Market Overview

    29.2. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Catheter-Related Bloodstream Infection Market Competitive Landscape And Company Profiles

    30.1. Catheter-Related Bloodstream Infection Market Competitive Landscape

    30.2. Catheter-Related Bloodstream Infection Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Services Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novartis AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. 3M Company

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Eli Lilly and Company

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Catheter-Related Bloodstream Infection Market Other Major And Innovative Companies

    31.1. Fresenius Medical Care AG & Co. KGaA

    31.2. Becton Dickinson and Company

    31.3. Viatris Inc.

    31.4. B. Braun Medical Inc.

    31.5. Aurobindo Pharma Limited

    31.6. Lupin Ltd.

    31.7. Xellia Pharmaceuticals Ltd.

    31.8. SteriMax Inc.

    31.9. Geistlich Pharma AG

    31.10. Bactiguard AB

    31.11. Hetero Healthcare Ltd.

    31.12. TauroPharm GmbH

    31.13. Advacare Pharma

    31.14. Citus Pharmaceuticals Inc.

    31.15. CorMedix Inc.

    32. Global Catheter-Related Bloodstream Infection Market Competitive Benchmarking

    33. Global Catheter-Related Bloodstream Infection Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Catheter-Related Bloodstream Infection Market

    35. Catheter-Related Bloodstream Infection Market Future Outlook and Potential Analysis

    35.1 Catheter-Related Bloodstream Infection Market In 2028 - Countries Offering Most New Opportunities

    35.2 Catheter-Related Bloodstream Infection Market In 2028 - Segments Offering Most New Opportunities

    35.3 Catheter-Related Bloodstream Infection Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Catheter-Related Bloodstream Infection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Catheter-Related Bloodstream Infection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Johnson & Johnson Services Inc. Financial Performance
  • Table 76: Novartis AG Financial Performance
  • Table 77: 3M Company Financial Performance
  • Table 78: Eli Lilly and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Catheter-Related Bloodstream Infection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Catheter-Related Bloodstream Infection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Johnson & Johnson Services Inc. Financial Performance
  • Figure 76: Novartis AG Financial Performance
  • Figure 77: 3M Company Financial Performance
  • Figure 78: Eli Lilly and Company Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the catheter-related bloodstream infection market?

Catheter-related bloodstream infection (CRBSI) is a type of infection that occurs when bacteria or fungi enter the bloodstream through a catheter, a tube inserted into a vein to deliver medications or nutrients. It is a serious healthcare-associated infection that can lead to sepsis and other complications. Prompt diagnosis and treatment are essential to prevent severe outcomes. For further insights on the catheter-related bloodstream infection market, request a sample here

How will the catheter-related bloodstream infection market drivers and restraints affect the catheter-related bloodstream infection market dynamics? What forces will shape the catheter-related bloodstream infection industry going forward?

The catheter-related bloodstream infection market major growth driver - Impact Of Hospital-Acquired Infections On The Catheter-Related Bloodstream Infection Market. For further insights on the catheter-related bloodstream infection market, request a sample here

What is the forecast market size or the forecast market value of the catheter-related bloodstream infection market?

The catheter-related bloodstream infection market size has grown strongly in recent years. It will grow from $1.44 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising incidence of chronic diseases, increased awareness and education, rise in hospital-acquired infections, the growing elderly population, and enhanced infection control programs in hospitals and healthcare settings. The catheter-related bloodstream infection market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing healthcare-associated infections (hais), rising awareness and training, enhanced awareness and training programs on infection control practices, expansion of healthcare infrastructure, increase in geriatric population, supportive government policies and initiatives. Major trends in the forecast period include biomaterial innovations, smart catheter technology, the development of more effective catheter lock solutions with advanced antimicrobial properties, innovations in sterilization processes for catheters, and automated flushing systems. For further insights on the catheter-related bloodstream infection market, request a sample here

How is the catheter-related bloodstream infection market segmented?

The catheter-related bloodstream infection market is segmented
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneuminiae), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginsa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online PharmaciesFor further insights on the catheter-related bloodstream infection market,
request a sample here

Which region has the largest share of the catheter-related bloodstream infection market? What are the other regions covered in the report?

North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the catheter-related bloodstream infection market, request a sample here.

Who are the major players in the catheter-related bloodstream infection market?

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC For further insights on the catheter-related bloodstream infection market, request a sample here.

What are the key trends in the catheter-related bloodstream infection market?

Major trend in the catheter-related bloodstream infection market - Innovative Catheter Lock Solutions Enhanced Catheter-Related Bloodstream Infection Market. For further insights on the catheter-related bloodstream infection market, request a sample here.

What are the major opportunities in the catheter-related bloodstream infection market? What are the strategies for the catheter-related bloodstream infection market?

For detailed insights on the major opportunities and strategies in the catheter-related bloodstream infection market, request a sample here.

How does the catheter-related bloodstream infection market relate to the overall economy and other similar markets?

For detailed insights on catheter-related bloodstream infection market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the catheter-related bloodstream infection industry?

For detailed insights on the mergers and acquisitions in the catheter-related bloodstream infection industry, request a sample here.

What are the key dynamics influencing the catheter-related bloodstream infection market growth? SWOT analysis of the catheter-related bloodstream infection market.

For detailed insights on the key dynamics influencing the catheter-related bloodstream infection market growth and SWOT analysis of the catheter-related bloodstream infection industry, request a sample here.